Brown 2006.
Study characteristics | ||
Methods | Study design: RCT Number randomized: 115; 57 to the exercise group and 58 to the control group Study start and stop dates: not reported Length of intervention: 4 weeks Length of follow‐up: 4, 7, and 27 weeks after baseline |
|
Participants | Type cancer, n (%): various
Time since cancer diagnosis: not reported Time in active treatment: not reported Inclusion criteria:
Eligibility criteria related to interest or ability, or both, to exercise:
Exclusion criteria:
Gender, n (%):
Current age, n (%):
Age at cancer diagnosis: not reported Ethnicity/race: all patients were white or of unknown ethnicity Education level: not reported SES: not reported Employment status, currently employed, n (%):
Comorbidities: not reported Past exercise history: not reported On hormone therapy: not reported |
|
Interventions | 57 participants assigned to the exercise intervention, including:
Type exercise (aerobic/anaerobic): aerobic and anaerobic Intensity of the experimental exercise intervention: not reported Frequency: twice per week Duration of individual sessions: 90 minutes Duration of exercise program: 4 weeks Total number of exercise sessions: 8 sessions Format: group Facility: facility Professionally led by a physical therapist Adherence: 78% of participants attended all sessions, 92% attended all but 1 session. No subject missed more than 2 sessions 58 participants assigned to control group, including:
Contamination of control group: not reported |
|
Outcomes | Primary outcome:
Other outcomes included:
Outcomes were measured at baseline, 4 weeks, 7 weeks, and 27 weeks:
Subgroup analysis: none reported Adverse events: not reported |
|
Notes | Country: US Funding: Linse Bock Foundation, Saint Mary's Hospital Sponsorship Board |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | The generation of the random sequence was not described |
Allocation concealment (selection bias) | Unclear risk | Whether the treatment assignment was concealed from study personnel and participants was not described |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Owing to the nature of the intervention, it was not possible to conceal allocation to the intervention from the participants |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Allocation to the intervention was not concealed from the study personnel |
Incomplete outcome data (attrition bias) All outcomes | High risk | The number of participants who withdrew from the study was not reported beyond the 4‐week period. An ITT analysis was not completed |
Selective reporting (reporting bias) | High risk | The authors describe some QoL measures in the methods for which no results are presented |
Other bias | Low risk | The trial appears to be free of other problems that could put it at a high risk of bias |